Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1987 1
1988 1
1989 1
1990 1
1991 1
1993 1
1994 1
1995 2
1996 3
2003 1
2004 1
2006 1
2007 1
2010 3
2011 1
2014 1
2016 3
2017 2
2018 5
2019 4
2020 6
2021 2
2022 5
2023 6

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Artemisinin resistance and malaria elimination: Where are we now?
Hanboonkunupakarn B, Tarning J, Pukrittayakamee S, Chotivanich K. Hanboonkunupakarn B, et al. Among authors: pukrittayakamee s. Front Pharmacol. 2022 Sep 23;13:876282. doi: 10.3389/fphar.2022.876282. eCollection 2022. Front Pharmacol. 2022. PMID: 36210819 Free PMC article. Review.
The suggested ACT modifications are extension of the duration of the ACT course, alternating use of different ACT regimens, and addition of another antimalarial drug to the standard ACTs (Triple-ACT). Furthermore, a malaria vaccine (e.g., RTS,S vaccine) could be added to m …
The suggested ACT modifications are extension of the duration of the ACT course, alternating use of different ACT regimens, and addition of …
RTS,S/AS01, a vaccine targeting pre-erythrocytic stages of Plasmodium falciparum.
von Seidlein L, Hanboonkunupakarn B, Jittmala P, Pukrittayakamee S. von Seidlein L, et al. Among authors: pukrittayakamee s. Emerg Top Life Sci. 2017 Dec 22;1(6):533-537. doi: 10.1042/ETLS20170101. Emerg Top Life Sci. 2017. PMID: 33525840
RTS,S/AS01 is the most advanced vaccine to prevent malaria. It is safe and moderately effective. ...Such novel approaches aim to extract the maximum benefit from the well-documented, short-lasting protective efficacy of RTS,S/AS01....
RTS,S/AS01 is the most advanced vaccine to prevent malaria. It is safe and moderately effective. ...Such novel approaches aim to extr …
Therapeutic responses to antimalarial and antibacterial drugs in vivax malaria.
Pukrittayakamee S, Imwong M, Looareesuwan S, White NJ. Pukrittayakamee S, et al. Acta Trop. 2004 Feb;89(3):351-6. doi: 10.1016/j.actatropica.2003.10.012. Acta Trop. 2004. PMID: 14744561 Review.
For accurate comparison of relapse/recrudescence rates in vivax malaria, at least 2 month's follow-up is required. It can be concluded that in malarious areas of Thailand, double infection with P. falciparum and P. vivax is common affecting at least 25% of the patients and …
For accurate comparison of relapse/recrudescence rates in vivax malaria, at least 2 month's follow-up is required. It can be conclude …
Artemisinin resistance in the malaria parasite, Plasmodium falciparum, originates from its initial transcriptional response.
Zhu L, van der Pluijm RW, Kucharski M, Nayak S, Tripathi J, White NJ, Day NPJ, Faiz A, Phyo AP, Amaratunga C, Lek D, Ashley EA, Nosten F, Smithuis F, Ginsburg H, von Seidlein L, Lin K, Imwong M, Chotivanich K, Mayxay M, Dhorda M, Nguyen HC, Nguyen TNT, Miotto O, Newton PN, Jittamala P, Tripura R, Pukrittayakamee S, Peto TJ, Hien TT, Dondorp AM, Bozdech Z. Zhu L, et al. Among authors: pukrittayakamee s. Commun Biol. 2022 Mar 28;5(1):274. doi: 10.1038/s42003-022-03215-0. Commun Biol. 2022. PMID: 35347215 Free PMC article.
An open dataset of Plasmodium vivax genome variation in 1,895 worldwide samples.
MalariaGEN; Adam I, Alam MS, Alemu S, Amaratunga C, Amato R, Andrianaranjaka V, Anstey NM, Aseffa A, Ashley E, Assefa A, Auburn S, Barber BE, Barry A, Batista Pereira D, Cao J, Chau NH, Chotivanich K, Chu C, Dondorp AM, Drury E, Echeverry DF, Erko B, Espino F, Fairhurst R, Faiz A, Fernanda Villegas M, Gao Q, Golassa L, Goncalves S, Grigg MJ, Hamedi Y, Hien TT, Htut Y, Johnson KJ, Karunaweera N, Khan W, Krudsood S, Kwiatkowski DP, Lacerda M, Ley B, Lim P, Liu Y, Llanos-Cuentas A, Lon C, Lopera-Mesa T, Marfurt J, Michon P, Miotto O, Mohammed R, Mueller I, Namaik-Larp C, Newton PN, Nguyen TN, Nosten F, Noviyanti R, Pava Z, Pearson RD, Petros B, Phyo AP, Price RN, Pukrittayakamee S, Rahim AG, Randrianarivelojosia M, Rayner JC, Rumaseb A, Siegel SV, Simpson VJ, Thriemer K, Tobon-Castano A, Trimarsanto H, Urbano Ferreira M, Vélez ID, Wangchuk S, Wellems TE, White NJ, William T, Yasnot MF, Yilma D. MalariaGEN, et al. Among authors: pukrittayakamee s. Wellcome Open Res. 2022 Apr 14;7:136. doi: 10.12688/wellcomeopenres.17795.1. eCollection 2022. Wellcome Open Res. 2022. PMID: 35651694 Free PMC article.
The validity and reliability of the PHQ-9 in screening for post-stroke depression.
Dajpratham P, Pukrittayakamee P, Atsariyasing W, Wannarit K, Boonhong J, Pongpirul K. Dajpratham P, et al. Among authors: pukrittayakamee p. BMC Psychiatry. 2020 Jun 9;20(1):291. doi: 10.1186/s12888-020-02699-6. BMC Psychiatry. 2020. PMID: 32517743 Free PMC article.
The Thai PHQ-9 had satisfactory internal consistency (Cronbach's alpha: 0.78). The algorithm-based diagnosis of the Thai PHQ-9 had low sensitivity (0.52) but very high specificity (0.94) and positive likelihood ratio (9.6). ...
The Thai PHQ-9 had satisfactory internal consistency (Cronbach's alpha: 0.78). The algorithm-based diagnosis of the Thai PHQ-9 had lo …
Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers.
von Seidlein L, Hanboonkunupakarn B, Jittamala P, Pongsuwan P, Chotivanich K, Tarning J, Hoglund RM, Winterberg M, Mukaka M, Peerawaranun P, Sirithiranont P, Doran Z, Ockenhouse CF, Ivinson K, Lee C, Birkett AJ, Kaslow DC, Singhasivanon P, Day NPJ, Dondorp AM, White NJ, Pukrittayakamee S. von Seidlein L, et al. Among authors: pukrittayakamee s. Hum Vaccin Immunother. 2020;16(1):33-41. doi: 10.1080/21645515.2019.1643675. Epub 2019 Aug 15. Hum Vaccin Immunother. 2020. PMID: 31306084 Free PMC article. Clinical Trial.
Introduction: RTS,S/AS01 is currently the most advanced malaria vaccine but provides incomplete, short-term protection. ...No serious adverse events attributable to the study interventions were detected.Conclusion: This study found that RTS,S/AS01 with and without d …
Introduction: RTS,S/AS01 is currently the most advanced malaria vaccine but provides incomplete, short-term protection. ...No serious …
Spiroindolone KAE609 for falciparum and vivax malaria.
White NJ, Pukrittayakamee S, Phyo AP, Rueangweerayut R, Nosten F, Jittamala P, Jeeyapant A, Jain JP, Lefèvre G, Li R, Magnusson B, Diagana TT, Leong FJ. White NJ, et al. Among authors: pukrittayakamee s. N Engl J Med. 2014 Jul 31;371(5):403-10. doi: 10.1056/NEJMoa1315860. N Engl J Med. 2014. PMID: 25075833 Free PMC article. Clinical Trial.
Assessment In Vitro of the Antimalarial and Transmission-Blocking Activities of Cipargamin and Ganaplacide in Artemisinin-Resistant Plasmodium falciparum.
Yipsirimetee A, Chiewpoo P, Tripura R, Lek D, Day NPJ, Dondorp AM, Pukrittayakamee S, White NJ, Chotivanich K. Yipsirimetee A, et al. Among authors: pukrittayakamee s. Antimicrob Agents Chemother. 2022 Mar 15;66(3):e0148121. doi: 10.1128/AAC.01481-21. Epub 2022 Jan 3. Antimicrob Agents Chemother. 2022. PMID: 34978886 Free PMC article.
Ganaplacide had higher activities than cipargamin and artesunate, with mean (standard deviation [SD]) 50% inhibitory concentrations (IC(50)s) against asexual stages of 5.6 (1.2) nM and 6.9 (3.8) nM for male gametocytes and 47.5 (54.7) nM for female gametocytes. Cipargamin …
Ganaplacide had higher activities than cipargamin and artesunate, with mean (standard deviation [SD]) 50% inhibitory concentrations (IC(50) …
An open dataset of Plasmodium falciparum genome variation in 7,000 worldwide samples.
MalariaGEN; Ahouidi A, Ali M, Almagro-Garcia J, Amambua-Ngwa A, Amaratunga C, Amato R, Amenga-Etego L, Andagalu B, Anderson TJC, Andrianaranjaka V, Apinjoh T, Ariani C, Ashley EA, Auburn S, Awandare GA, Ba H, Baraka V, Barry AE, Bejon P, Bertin GI, Boni MF, Borrmann S, Bousema T, Branch O, Bull PC, Busby GBJ, Chookajorn T, Chotivanich K, Claessens A, Conway D, Craig A, D'Alessandro U, Dama S, Day NP, Denis B, Diakite M, Djimdé A, Dolecek C, Dondorp AM, Drakeley C, Drury E, Duffy P, Echeverry DF, Egwang TG, Erko B, Fairhurst RM, Faiz A, Fanello CA, Fukuda MM, Gamboa D, Ghansah A, Golassa L, Goncalves S, Hamilton WL, Harrison GLA, Hart L, Henrichs C, Hien TT, Hill CA, Hodgson A, Hubbart C, Imwong M, Ishengoma DS, Jackson SA, Jacob CG, Jeffery B, Jeffreys AE, Johnson KJ, Jyothi D, Kamaliddin C, Kamau E, Kekre M, Kluczynski K, Kochakarn T, Konaté A, Kwiatkowski DP, Kyaw MP, Lim P, Lon C, Loua KM, Maïga-Ascofaré O, Malangone C, Manske M, Marfurt J, Marsh K, Mayxay M, Miles A, Miotto O, Mobegi V, Mokuolu OA, Montgomery J, Mueller I, Newton PN, Nguyen T, Nguyen TN, Noedl H, Nosten F, Noviyanti R, Nzila A, Ochola-Oyier LI, Ocholla H, Oduro A, Omedo I, Onyamboko MA, Ouedraogo JB, Oyebola K… See abstract for full author list ➔ MalariaGEN, et al. Among authors: pukrittayakamee s. Wellcome Open Res. 2021 Jul 13;6:42. doi: 10.12688/wellcomeopenres.16168.2. eCollection 2021. Wellcome Open Res. 2021. PMID: 33824913 Free PMC article.
53 results